FASN and chronic myelogenous leukemia, BCR-ABL1 positive: We chose the chronic myeloid leukemia (CML)-derived, near-haploid cell line HAP1, in which CRISPR/Cas9-mediated knockdown of the FASN gene has been previously established as a suitable model system for defective de novo FA synthesis [37, 38].